 Connection
Amy Shah to Prognosis
This is a "connection" page, showing publications Amy Shah has written about Prognosis.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.130 |
|
|
|
-
Valdez Y, Segev N, Parimi N, Vegesna M, Brown EA, Samuels S, Van Name M, Shah AS, Wolf RM. Real-world effectiveness of tirzepatide among youth with type 2 diabetes and/or obesity: a multicenter analysis. J Pediatr Endocrinol Metab. 2026 Oct 26; 39(10):1007-1016.
Score: 0.032
-
Kreienkamp RJ, Smith K, Wangden TY, Deutsch AJ, Gage SD, Bellatorre A, Dabelea DM, D'Agostino RB, Dolan LM, Florez JC, Jensen ET, Pihoker C, Pollin TI, Shah AS, Szczerbinski L, Udler MS, Srinivasan S. Novel Phenotypic Clusters of Youth-Onset Type 2 Diabetes Offer No Added Prognostic Value to Simple Clinical Measures. Diabetes Care. 2026 01 01; 49(1):137-146.
Score: 0.031
-
Timkovski M, Patel D, Brown EA, Magella B, Shah AS, Wolf RM. Real-world effectiveness of sodium glucose transporter 2 inhibitors among youth with type 2 diabetes. J Pediatr Endocrinol Metab. 2025 Nov 25; 38(11):1161-1168.
Score: 0.030
-
Ashraf AP, Sunil B, Bamba V, Breidbart E, Brar PC, Chung S, Gupta A, Khokhar A, Kumar S, Lightbourne M, Kamboj MK, Miller RS, Patni N, Raman V, Shah AS, Wilson DP, Kohn B. Case Studies in Pediatric Lipid Disorders and Their Management. J Clin Endocrinol Metab. 2021 11 19; 106(12):3605-3620.
Score: 0.023
-
Maahs DM, Dabelea D, D'Agostino RB, Andrews JS, Shah AS, Crimmins N, Mayer-Davis EJ, Marcovina S, Imperatore G, Wadwa RP, Daniels SR, Reynolds K, Hamman RF, Dolan LM. Glucose control predicts 2-year change in lipid profile in youth with type 1 diabetes. J Pediatr. 2013 Jan; 162(1):101-7.e1.
Score: 0.012
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|